TickerFacts.

A business in context

MRNA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-01 · 0001682852-26-000167

  2. 4 · Ownership change

    Report date 2026-09-01 · 0001682852-26-000165

  3. 4 · Ownership change

    Report date 2026-09-01 · 0001682852-26-000163

  4. 8-K · Current report

    Report date 2026-08-27 · 0001193125-26-378505 · Items 1.01,2.03,3.02,8.01,9.01

  5. 4 · Ownership change

    Report date 2026-08-27 · 0001682852-26-000161

  6. 4 · Ownership change

    Report date 2026-08-27 · 0001682852-26-000157

  7. 4 · Ownership change

    Report date 2026-08-27 · 0001682852-26-000155

  8. 4 · Ownership change

    Report date 2026-08-05 · 0001682852-26-000153

  9. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001682852-26-000150

  10. 8-K · Current report

    Report date 2026-07-31 · 0001682852-26-000147 · Items 2.02,9.01

  11. 4 · Ownership change

    Report date 2026-07-15 · 0001682852-26-000141

  12. 8-K · Current report

    Report date 2026-07-06 · 0001682852-26-000134 · Items 5.02,7.01,9.01

  13. 8-K · Current report

    Report date 2026-05-06 · 0001682852-26-000101 · Items 5.03,5.07,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001682852-26-000060

  15. 8-K · Current report

    Report date 2026-05-01 · 0001682852-26-000057 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-05-06 · 0001308179-26-000081

  17. 8-K · Current report

    Report date 2026-03-03 · 0001682852-26-000047 · Items 1.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001682852-26-000033

  19. 8-K · Current report

    Report date 2026-02-13 · 0001682852-26-000015 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2026-02-03 · 0001682852-26-000012 · Items 7.01,8.01,9.01

  21. 8-K · Current report

    Report date 2026-01-12 · 0001682852-26-000007 · Items 2.02,7.01,9.01

  22. 8-K · Current report

    Report date 2026-01-05 · 0001682852-26-000003 · Items 7.01,9.01

  23. 8-K · Current report

    Report date 2025-11-19 · 0001628280-25-053816 · Items 1.01,2.03,9.01

  24. 8-K · Current report

    Report date 2025-11-20 · 0001628280-25-053318 · Items 7.01,9.01

  25. 8-K · Current report

    Report date 2025-11-12 · 0001628280-25-052055 · Items 5.07

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001682852-25-000075

  27. 8-K · Current report

    Report date 2025-11-06 · 0001682852-25-000073 · Items 2.02,9.01

  28. DEF 14A · Proxy statement

    Report date 2025-11-12 · 0001682852-25-000062

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001682852-25-000044

  30. 8-K · Current report

    Report date 2025-08-01 · 0001682852-25-000041 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-04-30 · 0001682852-25-000036 · Items 5.07

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001682852-25-000034

  33. 8-K · Current report

    Report date 2025-05-01 · 0001682852-25-000031 · Items 2.02,9.01

  34. DEF 14A · Proxy statement

    Report date 2025-04-30 · 0001308179-25-000082

  35. 10-K · Annual report

    Report date 2024-12-31 · 0001682852-25-000022

  36. 8-K · Current report

    Report date 2025-02-14 · 0001682852-25-000006 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2025-01-13 · 0001682852-25-000002 · Items 2.02,7.01,9.01

  38. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001682852-24-000060

  39. 8-K · Current report

    Report date 2024-11-07 · 0001682852-24-000057 · Items 2.02,9.01

  40. 8-K · Current report

    Report date 2024-09-28 · 0001682852-24-000052 · Items 5.02,7.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 5 transaction rows5SGrant / award: 10 transaction rows10AExercise / conversion: 48 transaction rows48MTax / exercise payment: 12 transaction rows12FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

75 matching transaction rows. Showing 51–75.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-06
2026-05-08
Rubenstein David M.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
9681.00.0
2026-05-06
2026-05-08
Hussain AbbasA · Grant / award
Acquired
Restricted Stock Units
Derivative security
8371.00.0
2026-05-06
2026-05-08
Horning SandraA · Grant / award
Acquired
Restricted Stock Units
Derivative security
2092.00.0
2026-05-06
2026-05-08
Horning SandraA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
9681.00.0
2026-05-06
2026-05-08
NABEL ELIZABETH GA · Grant / award
Acquired
Restricted Stock Units
Derivative security
8371.00.0
2026-05-06
2026-05-08
Nader FrancoisA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
6454.00.0
2026-05-06
2026-05-08
Nader FrancoisA · Grant / award
Acquired
Restricted Stock Units
Derivative security
4185.00.0
2026-05-06
2026-05-08
Tallett Elizabeth EA · Grant / award
Acquired
Restricted Stock Units
Derivative security
8371.00.0
2026-05-06
2026-05-08
AFEYAN NOUBARA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
12908.00.0
2026-05-01
2026-05-04
Hussain Abbas
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5682.046.63
2026-04-30
2026-05-04
Horning SandraM · Exercise / conversion
Acquired
Common Stock16233.0—
2026-04-30
2026-05-04
Horning SandraM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
16233.00.0
2026-04-30
2026-05-04
Rubenstein David M.M · Exercise / conversion
Acquired
Common Stock8116.0—
2026-04-30
2026-05-04
Rubenstein David M.M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
8116.00.0
2026-04-30
2026-05-04
Hussain Abbas
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock16233.0—
2026-04-30
2026-05-04
Hussain Abbas
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
16233.00.0
2026-04-30
2026-05-04
NABEL ELIZABETH GM · Exercise / conversion
Acquired
Common Stock16233.0—
2026-04-30
2026-05-04
NABEL ELIZABETH GM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
16233.00.0
2026-04-30
2026-05-04
Nader FrancoisM · Exercise / conversion
Acquired
Common Stock12174.0—
2026-04-30
2026-05-04
Nader FrancoisM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
12174.00.0
2026-04-30
2026-05-04
Tallett Elizabeth EM · Exercise / conversion
Acquired
Common Stock4058.0—
2026-04-30
2026-05-04
Tallett Elizabeth EM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
4058.00.0
2026-04-02
2026-04-06
Mock James MM · Exercise / conversion
Acquired
Common Stock1453.0—
2026-04-02
2026-04-06
Mock James MF · Tax / exercise payment
Disposed
Common Stock703.050.03
2026-04-02
2026-04-06
Mock James MM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
1453.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001682852Moderna, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300EI6OKH5K5Q2G38
GLEIF legal name
MODERNA, INC.
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2025-12-16T10:33:56Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Moderna · alias · wikidata
  • Moderna Therapeutics · alias · wikidata
  • Moderna Therapeutics, Inc. · alias · wikidata
  • Moderna Therapeutics, Inc. · former SEC name · 2016-08-24 to 2016-08-24
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$3.24B$3.44B
2023-12-31$6.85B$7.50B
2022-12-31$19.26B$21.98B
2021-12-31$18.47B$22.76B
2019-12-31$60.21M$78.64M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗